-
-
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection (OI) in AIDS patients. Laboratory diagnosis of this life-threatening infection is based primarily upon identifying P. jirovecii cysts in respiratory secretions, a technique that is variably sensitive and requires adequate patient effort (for induced sputum examination) or an invasive test (bronchoscopy); both are quite operator dependent.
-
Seven patients were identified when DAP-ASBL therapy was used to eradicate persistent MRSA bacteremia. Isolates from 3 patients were available for in vitro study.
-
In this issue: FDA issues multiple drug safety alerts; ARBs and cancer risk; and FDA actions.
-
The National Medication Error Reporting Program (operated by the Institute for Safe Medication Practices [ISMP]) recently issued an alert on the potential risk of medication errors associated with dosing colistimethate for injection.
-
-
The American Medical Association convened the biannual House of Delegates meeting in Chicago in June with more than 500 delegates from a variety of societies and organizations.
-
The Affordable Care Act (ACA) contains provisions for offering financial incentives for wellness participation in workplaces, which is good news for occupational health. However, the American Heart Association and the American Cancer Society have created a coalition to persuade federal regulators to prohibit financial incentives for Health Risk Assessments when family history items are involved.
-
Almost three in four (71%) of hospital-based health care workers received their flu vaccine last year, showing a sustained commitment to vaccination even after the pandemic subsided, according to a survey conducted by the Centers for Disease Control and Prevention.
-
Will employers facing soaring health care costs begin penalizing smokers or obese employees with higher premiums or surcharges?
